Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
Fiche publication
Date publication
octobre 2016
Journal
Anticancer research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier
Tous les auteurs :
Lemoine N, Adenis A, Bouche O, Duhamel A, Heurgue A, Leteurtre E, Amela E, Salleron J, Hebbar M
Lien Pubmed
Résumé
To evaluate the efficacy of first-line palliative chemotherapy, regarding the presence of signet ring cells (SRC).
Mots clés
Adenocarcinoma, drug therapy, Adult, Aged, Antineoplastic Agents, adverse effects, Carcinoma, Signet Ring Cell, drug therapy, Esophagogastric Junction, pathology, Female, Humans, Male, Middle Aged, Prognosis, Stomach Neoplasms, drug therapy, Survival Rate
Référence
Anticancer Res.. 2016 10;36(10):5543-5549